Reports for SANIS HEALTH INC

Company Name

SANIS HEALTH INC

Totals

Shortage reports

445

Actual shortage: 54 (12%)
Anticipated shortage: 15 (3%)
Avoided shortage: 8 (2%)
Resolved: 368 (83%)

Discontinuation Reports

68

To be discontinued: 7 (10%)
Discontinued: 51 (75%)
Reversed: 10 (15%)

Late reports

44 (9%)

Overdue reports

12 (16%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BUPROPION SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-12 2024-03-02 144044
BUPROPION SR 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-12 2024-03-02 144047
TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-22 2024-04-05 211102
TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-17 2024-02-29 216290
TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-20 2024-04-07 222839
QUETIAPINE FUMARATE XR 50MG TABLET (EXTENDED-RELEASE) Anticipated shortage 2024-03-26 2024-05-08 223344
QUETIAPINE FUMARATE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-25 2024-04-14 223281
QUETIAPINE FUMARATE XR 200MG TABLET (EXTENDED-RELEASE) Anticipated shortage 2024-03-26 2024-05-08 223380
QUETIAPINE FUMARATE XR 300MG TABLET (EXTENDED-RELEASE) Anticipated shortage 2024-03-26 2024-05-08 223365
QUETIAPINE FUMARATE XR 400MG TABLET (EXTENDED-RELEASE) Anticipated shortage 2024-03-26 2024-05-08 223373
ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-27 2024-05-08 223485
GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-26 2024-03-26 223456
GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-26 2024-03-27 223453
DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-25 2024-04-19 223265
NAPROXEN EC 250MG TABLET (ENTERIC-COATED) Resolved 2018-07-25 2018-12-11 56416
NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2018-05-16 2018-08-16 49537
DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Resolved 2017-04-10 2017-04-27 6274
DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Resolved 2019-03-16 2024-03-02 78849
RABEPRAZOLE EC 10MG TABLET (ENTERIC-COATED) Actual shortage 2023-12-26 2024-05-08 214284
RABEPRAZOLE EC 20MG TABLET (ENTERIC-COATED) Resolved 2023-07-18 2023-12-01 198918

Showing 21 to 40 of 445

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DILTIAZEM CD Discontinued 2020-02-27 2020-02-27 107353
DILTIAZEM CD Discontinued 2020-02-27 2020-02-27 107357
DILTIAZEM CD Discontinued 2020-02-27 2020-02-27 107364
DIVALPROEX Discontinued 2020-02-27 2020-02-27 107369
DIVALPROEX Discontinued 2020-02-27 2020-02-27 107372
DIVALPROEX Discontinued 2020-02-27 2020-02-27 107375
CLINDAMYCIN Discontinued 2020-02-27 2020-02-27 107379
CLINDAMYCIN Discontinued 2020-02-27 2020-02-27 107383

Showing 61 to 68 of 68